208 related articles for article (PubMed ID: 12867646)
1. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
[TBL] [Abstract][Full Text] [Related]
2. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
3. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).
Niewiesk S
Vaccine; 2001 Mar; 19(17-19):2250-3. PubMed ID: 11257342
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
5. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
Schlereth B; Germann PG; ter Meulen V; Niewiesk S
J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
8. Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.
Lührmann A; Tschernig T; Pabst R; Niewiesk S
Vaccine; 2005 Sep; 23(39):4721-6. PubMed ID: 15964669
[TBL] [Abstract][Full Text] [Related]
9. Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.
Fooks AR; Jeevarajah D; Lee J; Warnes A; Niewiesk S; ter Meulen V; Stephenson JR; Clegg JC
J Gen Virol; 1998 May; 79 ( Pt 5)():1027-31. PubMed ID: 9603317
[TBL] [Abstract][Full Text] [Related]
10. Use of cotton rats for preclinical evaluation of measles vaccines.
Wyde PR; Stittelaar KJ; Osterhaus AD; Guzman E; Gilbert BE
Vaccine; 2000 Aug; 19(1):42-53. PubMed ID: 10924785
[TBL] [Abstract][Full Text] [Related]
11. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
13. Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
Pasetti MF; Ramirez K; Resendiz-Albor A; Ulmer J; Barry EM; Levine MM
J Virol; 2009 Mar; 83(6):2789-94. PubMed ID: 19129445
[TBL] [Abstract][Full Text] [Related]
14. Mucosal adenovirus-vectored vaccine for measles.
Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN
Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
17. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.
Durbin AP; Skiadopoulos MH; McAuliffe JM; Riggs JM; Surman SR; Collins PL; Murphy BR
J Virol; 2000 Aug; 74(15):6821-31. PubMed ID: 10888621
[TBL] [Abstract][Full Text] [Related]
18. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
19. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
20. Cotton rats (Sigmodon hispidus): an animal model to study the pathogenesis of measles virus infection.
Niewiesk S
Immunol Lett; 1999 Jan; 65(1-2):47-50. PubMed ID: 10065626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
